BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wan J, Xia L, Xu W, Lu N. Expression and Function of miR-155 in Diseases of the Gastrointestinal Tract.Int J Mol Sci. 2016;17. [PMID: 27187359 DOI: 10.3390/ijms17050709] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Liu AR, Yan ZW, Jiang LY, Lv Z, Li YK, Wang BG. The role of non-coding RNA in the diagnosis and treatment of Helicobacter pylori-related gastric cancer, with a focus on inflammation and immune response. Front Med (Lausanne) 2022;9:1009021. [PMID: 36314013 DOI: 10.3389/fmed.2022.1009021] [Reference Citation Analysis]
2 Wu B, Yang J, Dai Y, Xiong L. Combination of the BISAP Score and miR-155 is Applied in Predicting the Severity of Acute Pancreatitis. IJGM 2022;Volume 15:7467-7474. [DOI: 10.2147/ijgm.s384068] [Reference Citation Analysis]
3 Hu L, Han D, Yu D, Ao D, Yang Z. Circulating Blood miR-155 and miR-21 Promote the Development of Acute Pancreatitis and Can Be Used to Assess the Risk Stratification of Pancreatitis. J Healthc Eng 2021;2021:2064162. [PMID: 34950438 DOI: 10.1155/2021/2064162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kudelova E, Holubekova V, Grendar M, Kolkova Z, Samec M, Vanova B, Mikolajcik P, Smolar M, Kudela E, Laca L, Lasabova Z. Circulating miRNA expression over the course of colorectal cancer treatment. Oncol Lett 2022;23:18. [PMID: 34868358 DOI: 10.3892/ol.2021.13136] [Reference Citation Analysis]
5 Haroun RA, Osman WH, Amin RE, Hassan AK, Abo-Shanab WS, Eessa AM. Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection. Pathology 2021:S0031-3025(21)00515-8. [PMID: 34838331 DOI: 10.1016/j.pathol.2021.09.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
6 Grillo TG, Quaglio AEV, Beraldo RF, Lima TB, Baima JP, Di Stasi LC, Sassaki LY. MicroRNA expression in inflammatory bowel disease-associated colorectal cancer. World J Gastrointest Oncol 2021; 13(9): 995-1016 [PMID: 34616508 DOI: 10.4251/wjgo.v13.i9.995] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Mody D, Verma V, Rani V. Modulating host gene expression via gut microbiome-microRNA interplay to treat human diseases. Crit Rev Microbiol 2021;47:596-611. [PMID: 34407384 DOI: 10.1080/1040841X.2021.1907739] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Vasapolli R, Venerito M, Schirrmeister W, Thon C, Weigt J, Wex T, Malfertheiner P, Link A. Inflammatory microRNAs in gastric mucosa are modulated by Helicobacter pylori infection and proton-pump inhibitors but not by aspirin or NSAIDs. PLoS One 2021;16:e0249282. [PMID: 33857171 DOI: 10.1371/journal.pone.0249282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Crossland RE, Norden J, Ghimire S, Juric MK, Pearce KF, Lendrem C, Collin M, Mischak-Weissinger E, Holler E, Greinix HT, Dickinson AM. Profiling Tissue and Biofluid miR-155-5p, miR-155*, and miR-146a-5p Expression in Graft vs. Host Disease. Front Immunol 2021;12:639171. [PMID: 33790910 DOI: 10.3389/fimmu.2021.639171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Witek P, Enguita FJ, Grzesiak M, Costa MC, Gabriel A, Koziorowski M, Slomczynska M, Knapczyk-Stwora K. Effects of neonatal exposure to methoxychlor on corpus luteum in gilts: A transcriptomic analysis. Mol Reprod Dev 2021;88:238-48. [PMID: 33655673 DOI: 10.1002/mrd.23463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Yasseri S, Hassanzad M, Farnia P, Ghanavi J, Boloursaz M, Velayati AA. Evaluation of miR-155 Expression in Cystic Fibrosis Patients. J Compr Ped 2020;11. [DOI: 10.5812/compreped.100938] [Reference Citation Analysis]
12 Shao X, Li J, Xu F, Chen D, Liu K. MiR-155-Mediated Deregulation of GPER1 Plays an Important Role in the Gender Differences Related to Inflammatory Bowel Disease. Can J Infect Dis Med Microbiol 2020;2020:8811477. [PMID: 33014211 DOI: 10.1155/2020/8811477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Rashid H, Hossain B, Siddiqua T, Kabir M, Noor Z, Ahmed M, Haque R. Fecal MicroRNAs as Potential Biomarkers for Screening and Diagnosis of Intestinal Diseases. Front Mol Biosci 2020;7:181. [PMID: 32850969 DOI: 10.3389/fmolb.2020.00181] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
14 Guz M, Dworzański T, Jeleniewicz W, Cybulski M, Kozicka J, Stepulak A, Celiński K. Elevated miRNA Inversely Correlates with E-cadherin Gene Expression in Tissue Biopsies from Crohn Disease Patients in contrast to Ulcerative Colitis Patients. Biomed Res Int 2020;2020:4250329. [PMID: 32775420 DOI: 10.1155/2020/4250329] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Li Y, Tian Z, Tan Y, Lian G, Chen S, Chen S, Li J, Li X, Huang K, Chen Y. Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer. Mol Cancer 2020;19:109. [PMID: 32580736 DOI: 10.1186/s12943-020-01229-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
16 Al-Mustanjid M, Mahmud SMH, Royel MRI, Rahman MH, Islam T, Rahman MR, Moni MA. Detection of molecular signatures and pathways shared in inflammatory bowel disease and colorectal cancer: A bioinformatics and systems biology approach.Genomics. 2020;112:3416-3426. [PMID: 32535071 DOI: 10.1016/j.ygeno.2020.06.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
17 Lao TD, Le TAH. Association Between LMP-1, LMP-2, and miR-155 Expression as Potential Biomarker in Nasopharyngeal Carcinoma Patients: A Case/Control Study in Vietnam. Genet Test Mol Biomarkers 2019;23:815-22. [PMID: 31693455 DOI: 10.1089/gtmb.2019.0089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Zeng Z, Mukherjee A, Zhang H. From Genetics to Epigenetics, Roles of Epigenetics in Inflammatory Bowel Disease. Front Genet. 2019;10:1017. [PMID: 31737035 DOI: 10.3389/fgene.2019.01017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
19 Ou Y, Ren H, Zhao R, Song L, Liu Z, Xu W, Liu Y, Wang S. Helicobacter pylori CagA promotes the malignant transformation of gastric mucosal epithelial cells through the dysregulation of the miR-155/KLF4 signaling pathway. Mol Carcinog 2019;58:1427-37. [PMID: 31162747 DOI: 10.1002/mc.23025] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
20 Wan J, Yang X, Ren Y, Li X, Zhu Y, Haddock AN, Ji B, Xia L, Lu N. Inhibition of miR-155 reduces impaired autophagy and improves prognosis in an experimental pancreatitis mouse model. Cell Death Dis 2019;10:303. [PMID: 30944299 DOI: 10.1038/s41419-019-1545-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 7.7] [Reference Citation Analysis]
21 Chen H, Xu Z, Liu D. Small non-coding RNA and colorectal cancer. J Cell Mol Med 2019;23:3050-7. [PMID: 30801950 DOI: 10.1111/jcmm.14209] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 14.0] [Reference Citation Analysis]
22 Zou D, Xu L, Li H, Ma Y, Gong Y, Guo T, Jing Z, Xu X, Zhang Y. Role of abnormal microRNA expression in Helicobacter pylori associated gastric cancer. Crit Rev Microbiol 2019;45:239-51. [PMID: 30776938 DOI: 10.1080/1040841X.2019.1575793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Huang J, Li Y, Ma F, Kang Y, Liu Z, Wang J. Identification and characterization of microRNAs in the liver of rainbow trout in response to heat stress by high-throughput sequencing. Gene 2018;679:274-81. [DOI: 10.1016/j.gene.2018.09.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
24 Luan X, Zhou X, Naqvi A, Francis M, Foyle D, Nares S, Diekwisch TGH. MicroRNAs and immunity in periodontal health and disease. Int J Oral Sci 2018;10:24. [PMID: 30078842 DOI: 10.1038/s41368-018-0025-y] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 13.8] [Reference Citation Analysis]
25 Wei H, Li Y, Ning Q, Suo ZM. Regulation of miR-155 affects the invasion and migration of gastric carcinoma cells by modulating the STAT3 signaling pathway. Oncol Lett 2018;16:4137-42. [PMID: 30250530 DOI: 10.3892/ol.2018.9152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
26 Thorne L, Lu J, Chaudhry Y, Goodfellow I. miR-155 induction is a marker of murine norovirus infection but does not contribute to control of replication in vivo. Wellcome Open Res 2018;3:42. [PMID: 29900416 DOI: 10.12688/wellcomeopenres.14188.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
27 Liu J, Chen Z, Xiang J, Gu X. MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in vitro. Oncol Lett 2018;15:5561-8. [PMID: 29556299 DOI: 10.3892/ol.2018.8069] [Cited by in Crossref: 19] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
28 Ulivi P, Canale M, Passardi A, Marisi G, Valgiusti M, Frassineti GL, Calistri D, Amadori D, Scarpi E. Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer. Int J Mol Sci. 2018;19. [PMID: 29361687 DOI: 10.3390/ijms19010307] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 10.3] [Reference Citation Analysis]
29 Guo Y, Bao Y, Yang W. Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis. Int J Mol Sci 2017;18:E890. [PMID: 28441730 DOI: 10.3390/ijms18040890] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
30 Cao B, Zhou X, Ma J, Zhou W, Yang W, Fan D, Hong L. Role of MiRNAs in Inflammatory Bowel Disease. Dig Dis Sci. 2017;62:1426-1438. [PMID: 28391412 DOI: 10.1007/s10620-017-4567-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
31 Fernández C, Bellosillo B, Ferraro M, Seoane A, Sánchez-González B, Pairet S, Pons A, Barranco L, Vela MC, Gimeno E, Colomo L, Besses C, Navarro A, Salar A. MicroRNAs 142-3p, miR-155 and miR-203 Are Deregulated in Gastric MALT Lymphomas Compared to Chronic Gastritis. Cancer Genomics Proteomics 2017;14:75-82. [PMID: 28031239 DOI: 10.21873/cgp.20020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]